Piper Jaffray Initiates Auspex Pharma At Overweight

By: via Benzinga
Analysts at Piper Jaffray initiated coverage on shares of Auspex Pharma (NASDAQ: ASPX) with a Overweight rating. The target price for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.